ILLUMINA, INC. Cost-method Investments, Realized Gain (Loss)
ILLUMINA, INC. (ILMN) reported Cost-method Investments, Realized Gain (Loss) of $16.00 million for the 12-month period ending 2016-01-03, per its 10-K filed 2018-02-13.
Discontinued › Income Statement › Other Income
us-gaap:CostMethodInvestmentsRealizedGainLoss · last filed 2018-02-13
- ILLUMINA, INC. cost-method investments, realized gain (loss) for the quarter ending 2016-01-03 was $518.00K.
- ILLUMINA, INC. cost-method investments, realized gain (loss) for the quarter ending 2015-09-27 was $2.90M, a 34.49% decline year-over-year.
- ILLUMINA, INC. cost-method investments, realized gain (loss) for the quarter ending 2015-06-28 was $0.00.
- ILLUMINA, INC. cost-method investments, realized gain (loss) for the quarter ending 2015-03-29 was $12.58M.
- ILLUMINA, INC. cost-method investments, realized gain (loss) for fiscal 2016 was $16.00M, a 261.42% increase from fiscal 2014.
- ILLUMINA, INC. cost-method investments, realized gain (loss) for fiscal 2014 was $4.43M, a 92.78% decline from fiscal 2013.
- ILLUMINA, INC. cost-method investments, realized gain (loss) for fiscal 2013 was $61.36M, a 33.64% increase from fiscal 2012.
- ILLUMINA, INC. cost-method investments, realized gain (loss) for fiscal 2012 was $45.91M.
| Period end | Cost-method Investments, Realized Gain (Loss) 3 month | Cost-method Investments, Realized Gain (Loss) 3 month as first filed | Cost-method Investments, Realized Gain (Loss) 6 month | Cost-method Investments, Realized Gain (Loss) 9 month | Cost-method Investments, Realized Gain (Loss) 12 month | Cost-method Investments, Realized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2016-01-03 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $3.42M derived: sum of 2 quarters · filed 2018-02-13 | $3.42M derived: sum of 3 quarters · filed 2018-02-13 | $16.00M 10-K · filed 2018-02-13 | $15.60M 10-K · filed 2016-03-02 | |
| 2015-09-27 | $2.90M 10-Q · filed 2016-11-08 | $2.90M derived: sum of 2 quarters · filed 2016-11-08 | $15.48M 10-Q · filed 2016-11-08 | $15.48M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $12.58M 10-Q · filed 2016-08-02 | $12.58M derived: sum of 3 quarters · filed 2017-02-14 | $17.01M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-03-29 | $12.58M 10-Q · filed 2016-05-09 | $12.58M derived: sum of 2 quarters · filed 2017-02-14 | $17.01M derived: sum of 3 quarters · filed 2017-02-14 | |||
| 2014-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $4.43M derived: sum of 2 quarters · filed 2017-02-14 | $4.43M 10-K · filed 2017-02-14 | |||
| 2014-09-28 | $4.43M 10-Q · filed 2015-11-02 | $4.43M 10-Q · filed 2015-11-02 | ||||
| 2014-06-29 | $6.10M 10-Q · filed 2014-08-01 | |||||
| 2013-12-29 | $55.24M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | $55.24M derived: sum of 2 quarters · filed 2016-03-02 | $55.26M derived: sum of 3 quarters · filed 2016-03-02 | $61.36M 10-K · filed 2016-03-02 | ||
| 2013-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $13.00K derived: sum of 2 quarters · filed 2014-10-29 | $6.11M 10-Q · filed 2014-10-29 | |||
| 2013-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $6.11M 10-Q · filed 2014-08-01 | ||||
| 2013-03-31 | $6.10M 10-Q · filed 2014-10-29 | $6.11M 10-Q · filed 2013-05-01 | ||||
| 2012-12-30 | $45.91M 10-K · filed 2015-02-18 | |||||
| 2011-01-02 | -$10.31M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |